Skip to main content

Cancer

22
Feb 2024

NHS Cancer Programme Innovation Open Call 3 announced in England

On January 26, 2024, NHS England announced the third round of the Innovation Open Call, funded by the NHS Cancer Programme. All types of late-stage innovations aimed at early detection and diagnosis of cancer are eligible, including medical devices, in-vitro diagnostics, digital health solutions, and AI. Awarded projects will be 100% funded up to the total value of £4 million to produce and evaluate evidence in a real-world setting, supporting adoption and spread by providers, commissioners, and regulators. The application submission will be open on April 8, 2024.
13
Feb 2024

New Order relating to cancer screening programs published in France

In January 2024, the Ministry of Health and Prevention published the Order in the Official Journal of the French Republic updating the cancer screening programs. The new Order replaces the previous one from September 2006 and specifies the implementation conditions for the organized screening programs for breast, colorectal, and cervical cancers.
11
Jan 2024

Med Tech-related health technology assessments from NIHR in December 2023

In December 2023, the National Institute for Health and Care Research (NIHR) in England released two MedTech-related assessments in its Health Technology Assessment (HTA) Journal, which concerned ablative and non-surgical therapies for hepatocellular carcinoma and hidradenitis suppurativa treatment. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
08
Dec 2023

Med Tech-related health technology assessments from NIHR in November 2023

In November 2023, the National Institute for Health and Care Research (NIHR) in England released one MedTech-related assessment in its Health Technology Assessment (HTA) Journal, which concerned posterior hypofractionated whole breast radiotherapy for early breast cancer treatment. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
17
Oct 2023

Specialized clinical commissioning policies work plan updated in October 2023

On October 10, 2023, NHS England published an updated work plan for specialized clinical commissioning policies development (as of October 2, 2023). Two MedTech-related policies were added to the program: Gamma Knife stereotactic radiosurgery for essential tremor in adults; Stereotactic Ablative Radiotherapy for the treatment of primary kidney cancer. The status of ongoing policies was updated.
03
Oct 2023

Med Tech-related technology assessments and clinical guidelines from NICE in September 2023

In September 2023, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (removal, preservation, and reimplantation of ovarian tissue for restoring fertility, transurethral water-jet ablation for lower urinary tract symptoms, cryotherapy for chronic rhinitis), and three Health Technology Evaluations using early value assessment (AI-derived software to analyze chest X-rays for suspected lung cancer, AI technologies to aid contouring for radiotherapy planning, KardiaMobile 6L for adults having antipsychotic medication). Also, two new clinical guidelines were published, and three were updated.
18
Sep 2023

New version of the CCAM Nomenclature published in France

At early September 2023, the new version of the classification of procedure codes (CCAM v.73) was published. Several changes were introduced, including the creation of two permanent codes, one provisionally registered code, and three new grouping codes for 280 dental procedures.
31
Aug 2023

MedTech-related technology assessments and clinical guidelines from NICE in August 2023

In August 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease) and one new Diagnostic Guidance (quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care). Also, five clinical guidelines were updated.